Detalles de la búsqueda
1.
Aberrant activation of AXL may drive progression of squamous cell carcinoma in CLL patients: a mechanistic study with clinical implications.
Br J Cancer
; 2024 Jun 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38886556
2.
Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair.
Blood
; 137(4): 513-523, 2021 01 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33507295
3.
Leukemic extracellular vesicles induce chimeric antigen receptor T cell dysfunction in chronic lymphocytic leukemia.
Mol Ther
; 29(4): 1529-1540, 2021 04 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33388419
4.
Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre.
Br J Haematol
; 183(3): 421-427, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30117139
5.
Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study.
Am J Hematol
; 92(8): 759-763, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28402581
6.
The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy.
Blood
; 117(6): 1928-37, 2011 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-21135257
7.
AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells.
Cancer Immunol Res
; 11(9): 1222-1236, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37378662
8.
Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch.
Blood
; 116(16): 2984-93, 2010 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-20606160
9.
B cell receptor signaling drives APOBEC3 expression via direct enhancer regulation in chronic lymphocytic leukemia B cells.
Blood Cancer J
; 12(7): 99, 2022 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35778390
10.
B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome.
Blood
; 113(18): 4188-96, 2009 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-19015397
11.
SIRT3 overexpression and epigenetic silencing of catalase regulate ROS accumulation in CLL cells activating AXL signaling axis.
Blood Cancer J
; 11(5): 93, 2021 05 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34001853
12.
Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression.
Br J Haematol
; 147(4): 471-83, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19751240
13.
Analytical Considerations in Nanoscale Flow Cytometry of Extracellular Vesicles to Achieve Data Linearity.
Thromb Haemost
; 118(9): 1612-1624, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30112749
14.
Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy.
Oncotarget
; 9(98): 37173-37184, 2018 Dec 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30647852
15.
Upregulation of AXL and ß-catenin in chronic lymphocytic leukemia cells cultured with bone marrow stroma cells is associated with enhanced drug resistance.
Blood Cancer J
; 11(2): 37, 2021 02 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33602892
16.
Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia B Cells to Apoptosis and Shows Synergistic/Additive Effects in Combination with BTK Inhibitors.
Clin Cancer Res
; 21(9): 2115-26, 2015 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25673699
17.
Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia.
J Clin Oncol
; 27(24): 3959-63, 2009 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-19620484
Resultados
1 -
17
de 17
1
Próxima >
>>